Z-Tech (India) (ZTECH)

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 73.94% indicates strong demand and business momentum.
• ROCE of 28.12% shows highly efficient use of capital.
• Piotroski F-score of 7/9 reflects sound financial health.
• Promoter holding of 53.54% aligns management interests with shareholders.
• PEG ratio of 0.56 suggests growth is not fully reflected in the price.

Concerns

• P/E of 29.70 is expensive, and zero dividend yield offers no income cushion.
• Profit growth of 32.29% lags sales growth significantly, implying margin pressure.
• Book value and debt-equity data are not available, limiting margin-of-safety assessment.
• Latest quarterly profit may not be sustainable if growth or margins deteriorate.

AI Analysis

Let me examine Z-Tech (India) through a value lens. At ₹601.45, the market capitalises the company at ₹749 crore, and with a trailing P/E of 29.70, I am paying close to 30 years' worth of current earnings. That is rich for a business that pays no dividend. Mr. Graham would ask where the margin of safety is. The growth story is visible: sales expanded 73.94% last year, while profit grew 32.29%. Impressive, but notice the divergence—the bottom line is not keeping pace with the top line, suggesting either rising costs, reinvestment pressures, or competitive intensity. The latest quarter, however, is encouraging: sales of ₹42 crore and net profit of ₹8 crore imply a much lower forward P/E if sustained. The ROCE of 28.12% is exceptional, showing that capital employed is generating high returns. The Piotroski F-score of 7 out of 9 adds confidence in the financial health. Promoters holding 53.54% means their interests are aligned with mine. The PEG ratio of 0.56 suggests the market may be underpricing future growth. Yet, I remain cautious. There is no book value or debt-equity information furnished, so I cannot assess the balance sheet fully. A zero dividend yield forces me to rely entirely on expected price appreciation. If the company can deliver on its growth, the valuation may be justified; if not, there is a long way down. For me, this is a fast grower, not a classic value buy. I would watch it, but not at this price without greater certainty.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer